Discover
Stocks
Consumer Goods
ACAD
ACAD
ACADIA Pharmaceuticals Inc
26.25
0.36
(
1.39%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
ACAD
ACADIA Pharmaceuticals Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: ACADIA Pharmaceuticals Inc's revenues increased by 6.83% and amounted to 517.24M. Net income decreased by 28.66% to -215.98M. Net assets decreased by 25.97% to 400.41M and EPS decreased from -1.05 to -1.34.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment